Skip to main content
. 2017 Sep 13;45(20):e170. doi: 10.1093/nar/gkx787

Figure 7.

Figure 7.

The results on TCGA cancer data. (A) The iENA analysis on breast cancer (BRCA), where stage ii is identified as the tipping point. (B) The survival-day comparison for different breast cancer stages. (C) The survival analysis by coding-genes of edge-biomarkers on TCGA BRCA data. (D) The survival analysis by coding-genes of edge-biomarkers on GEO independent data. (E) The iENA analysis on liver cancer (LIHC), where stage ii is identified as the tipping point. (F) The survival-day comparison for different liver cancer stages. (G) The survival analysis by coding-genes of edge-biomarkers on TCGA LIHC data. (H) The survival analysis by coding-genes of edge-biomarkers on GEO independent data. Here, the edge-biomarkers are the DNB members.